Early Loss of Mitochondrial Complex I and Rewiring of Glutathione
Early loss of mitochondrial complex I and rewiring of PNAS PLUS glutathione metabolism in renal oncocytoma Raj K. Gopala,b,c,d, Sarah E. Calvoa,b,c, Angela R. Shihe, Frances L. Chavesf, Declan McGuonee, Eran Micka,b,c, Kerry A. Piercec, Yang Lia,g, Andrea Garofaloc,h, Eliezer M. Van Allenc,h, Clary B. Clishc, Esther Olivae, and Vamsi K. Moothaa,b,c,1 aHoward Hughes Medical Institute and Department of Molecular Biology, Massachusetts General Hospital, Boston, MA 02114; bDepartment of Systems Biology, Harvard Medical School, Boston, MA 02115; cBroad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA 02142; dDepartment of Hematology/Oncology, Massachusetts General Hospital, Boston, MA 02114; eDepartment of Pathology, Massachusetts General Hospital, Boston, MA 02114; fMolecular Pathology Unit, Massachusetts General Hospital, Boston, MA 02114; gDepartment of Statistics, Harvard University, Cambridge, MA 02138; and hDepartment of Medical Oncology, Dana–Farber Cancer Institute, Boston, MA 02215 Contributed by Vamsi K. Mootha, April 17, 2018 (sent for review July 6, 2017; reviewed by Ralph J. DeBerardinis and Robert A. Weinberg) Renal oncocytomas are benign tumors characterized by a marked electron transport chain (10, 11). Sequencing of nuclear DNA in accumulation of mitochondria. We report a combined exome, RO has revealed a low somatic mutation rate without recurrent transcriptome, and metabolome analysis of these tumors. Joint nuclear gene mutations, although recurrent chromosome 1 loss analysis of the nuclear and mitochondrial (mtDNA) genomes and cyclin D1 rearrangement have been reported (12, 13). reveals loss-of-function mtDNA mutations occurring at high vari- In this study, we report the results of profiling DNA, RNA, ant allele fractions, consistent with positive selection, in genes and metabolites in RO to investigate the molecular and bio- encoding complex I as the most frequent genetic events.
[Show full text]